SCHEMBL11908767

SCHEMBL11908767

CC(C)(C)[Si](C)(C)Oc1cc(-c2n[nH]c3ncnc(N)c23)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 16/20 0.43
PIK3CD O00329 15/20 0.43
PIK3CA P42336 15/20 0.43
PIK3CB P42338 15/20 0.43
PIK3CG P48736 15/20 0.43
PRKDC P78527 15/20 0.43
ABL1 P00519 15/20 0.43
KDR P35968 15/20 0.43
HCK P08631 14/20 0.43
MTOR P42345 14/20 0.43
EGFR P00533 13/20 0.43
EPHB4 P54760 13/20 0.43
PI4KB Q9UBF8 12/20 0.43
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10811 0.85 SRC (0.57) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL11908397 0.82 PREP (0.40) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL17331452 0.82 PIK3CD (0.37) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL11909455 0.81 PIK3CD (0.42) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL11306 0.78 SRC (0.47) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL149180 0.76 PIK3CD (0.55) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL11928101 0.76 PIK3CD (0.56) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL217790 0.76 ABL1 (0.49) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL13717800 0.75 CSNK1E (0.45) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL13717774 0.74 PIK3CD (0.41) SRCPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834560-B2 Compounds RESPIVERT LTD. (GB) 2017-12-05 US disclosed
US-20160264583-A1 COMPOUNDS RESPIVERT LTD. (GB) 2016-09-15 US disclosed
US-9321773-B2 Compounds Respivert, Ltd. (GB) 2016-04-26 US disclosed
US-20140249164-A1 COMPOUNDS RESPIVERT LTD (GB) 2014-09-04 US disclosed
US-8741909-B2 PI3 kinase inhibitors RESPIVERT LTD. (GB) 2014-06-03 US disclosed
US-20120208799-A1 COMPOUNDS RESPIVERT LTD (GB) 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264583-A1 COMPOUNDS LTC4S, CYP11B2, LTB4R2 SRC 4541/4885PIK3CD 4224/4885PIK3CA 3148/4885
US-20140249164-A1 COMPOUNDS LTC4S, CYP11B2, LTB4R2 SRC 4541/4885PIK3CD 4224/4885PIK3CA 3148/4885
US-20120208799-A1 COMPOUNDS LTC4S, CYP11B2, LTB4R2 SRC 4541/4885PIK3CD 4224/4885PIK3CA 3148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.